KLP Kapitalforvaltning AS Takes Position in Progyny, Inc. (NASDAQ:PGNY)

KLP Kapitalforvaltning AS acquired a new stake in Progyny, Inc. (NASDAQ:PGNY - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 35,300 shares of the company's stock, valued at approximately $609,000.

Several other institutional investors have also added to or reduced their stakes in PGNY. Signaturefd LLC grew its stake in shares of Progyny by 1,355.0% in the fourth quarter. Signaturefd LLC now owns 1,455 shares of the company's stock worth $25,000 after acquiring an additional 1,355 shares during the period. GAMMA Investing LLC raised its stake in Progyny by 341.4% during the 4th quarter. GAMMA Investing LLC now owns 1,611 shares of the company's stock valued at $28,000 after buying an additional 1,246 shares during the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Progyny by 108.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company's stock valued at $51,000 after buying an additional 1,526 shares during the period. Caitlin John LLC boosted its stake in shares of Progyny by 2,974.8% in the 4th quarter. Caitlin John LLC now owns 3,290 shares of the company's stock worth $57,000 after buying an additional 3,183 shares during the last quarter. Finally, SBI Securities Co. Ltd. bought a new stake in shares of Progyny in the fourth quarter worth $74,000. 94.93% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on PGNY shares. JPMorgan Chase & Co. increased their target price on Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a report on Tuesday, January 28th. Canaccord Genuity Group increased their price objective on shares of Progyny from $17.00 to $23.00 and gave the stock a "hold" rating in a research note on Friday, February 28th. Bank of America boosted their target price on shares of Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a research report on Tuesday, February 11th. Finally, BTIG Research raised shares of Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective for the company in a research report on Monday, March 31st. Eight investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $23.64.

Remove Ads

Progyny Stock Down 5.2 %

NASDAQ:PGNY traded down $1.17 on Monday, reaching $21.43. 1,714,677 shares of the company's stock traded hands, compared to its average volume of 1,714,309. The stock has a 50-day simple moving average of $22.16 and a 200-day simple moving average of $18.49. Progyny, Inc. has a 12 month low of $13.39 and a 12 month high of $36.36. The firm has a market cap of $1.83 billion, a PE ratio of 36.95, a P/E/G ratio of 2.39 and a beta of 1.33.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.